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1. Executive Summary 
This report outlines the operation and development of the GP-Community Partnership 
Addiction Project over its first three years of implementation (September 2006- 
September 2009).  The GP-Community Partnership Addiction Project is managed by the 
Ballymun Family Practice and funded by the Ballymun Local Drugs Task Force (BLDTF). 
The report presents the following:
• The aims and objectives of the Project and details of how it operates    
 (Chapter Two);
• The background of the Project and its development (Chapter Two);
• The research design and methodologies employed (Chapter Three);
• The effectiveness of a letter as a brief intervention technique for    
 benzodiazepine use (Chapter Four);
• The experience of having an addiction counsellor on site within the GP practice  
 environment from counsellors and GPs’ perspectives (Chapter Five). 
• Conclusions and Recommendations (Chapter Six)
The four general practices (who make up the Ballymun Family Practice) in Ballymun that 
took part in this research were successful in becoming part of local Primary Care Teams, 
announced in 2002 under the primary care strategy Primary Care – A New Direction 
(2001).  
The main aim of the GP - Community Addiction Project was to develop services for 
patients with benzodiazepine problems that present in primary care. The model proposed 
was that GPs in the practice would be supported by an addiction counsellor who would 
be integrated into each practice (working approximately 10 hours per week in total). 
Prior to project commencement, GPs received training in motivational interviewing 
from the local drug/alcohol training provider, URRÚS, in order to complement existing 
training/skills in this area or further develop these for use within the practices. Within the 
time period from January 2007 to December 2010, 124 patients of the Ballymun Family 
Practice attended the Addiction Counselling Service with the gender profile remaining 
largely the same (male: 58, female: 66). A range of addictions (i.e problematic use of 
other drugs apart from benzodiazepine use) were referred and presented to the GP – 
Community Partnership Addiction Project during this time.  The majority of referrals to 
the addiction project came through the GP practices. However local agencies could also 
refer their clients to the counsellor provided that he/she was registered with one of the 
practices. A review of referral forms from mid 2008 to the end of 2010 suggests that of 
those who attended the GP Addiction Project within this time period, a small minority 
reported benzodiazepine as the sole primary drug of choice (n=14). More significant, 
was the reported use of benzodiazepines as an additional drug with a large number of 
clients using benzodiazepines, not as their primary drug of choice (or its use as reason for 
referral), but alongside the problematic use of other drugs for example; alcohol, cocaine, 
methadone etc.
The project itself was developed as a response to a study published by the Ballymun 
Youth Action Project (BYAP) in 2004 entitled Benzodiazepines – Whose Little Helper?- The 
role of benzodiazepines in the development of substance misuse problems in Ballymun. 
The report highlighted an acceptance and normalisation of benzodiazepine use in 
Ballymun but also recommended the development of non-pharmaceutical alternatives to 
benzodiazepine prescribing. Recent research from the Health Research Board highlighted 
a national increase of just over 63% (from 1,054 in 2003 to 1,719 in 2008) in the number 
of cases reporting benzodiazepine as a problem substance.
A mixed method approach, in which both quantitative and qualitative methods were 
used, was adopted for this research. Prescriptions of benzodiazepines from the four 
practices were analysed quantitatively while qualitative research using focus groups with 
GPs and in-depth interviews with addiction counsellors was conducted.
The drugs, which were counted as part of the study included benzodiazepines such 
as Alprazolam (Xanax), Bromazepam (Lexotan) Chlordiazepoxide (Librium), Diazepam 
(Anxicalm, Valium) Flurazepam (Dalmane) Flunitrazepam (Rohypnol), Lormetazepam 
(Noctamid), Triazolam (Halcion), Temazepam (Nortem, Tenox). Also included as part of 
the list were drugs that are colloquially known as ‘Z drugs’.  These drugs while chemically 
different from benzodiazepines, have the same effects on the body and act by the same 
mechanisms.  The Z drugs that were counted were Zaleplon (Sonata), Zolpidem (Stilnoct), 
Zopiclone (Zimovane, Zopitan, Zileze).1
The quantitative aspect to this project aimed to determine whether the offer of 
the services of an addiction counsellor had additional benefits in the reduction of 
benzodiazepine use when added to a standardised letter sent to long-term users of 
benzodiazepines (n=134).2  Essentially two interventions were evaluated: a letter inviting 
patients to reduce their intake (sent to Group 1, n=54) and a letter inviting patients to 
reduce and to avail of the services of an addiction counsellor (sent to Group 2 including 
methadone protocol patients, n=80).  In 2000 the Ballymun Local Drugs Task Force, 
in their Revised Action Plan noted that benzodiazepine use was impeding progress 
for those on methadone maintenance programmes. As such it was decided to send 
methadone protocol patients the same letter as was sent to group 2 patients, and also to 
be in a position to extract their results as a distinct grouping (24/80 above). 
The brief intervention of a standard letter and the intervention of a letter with the offer 
of the services of an addiction counsellor did result in decreases in some prescription 
rates. The decrease was particularly noticeable in the cohort who was also availing of 
methadone maintenance treatment. It is also relevant to note that 6 out of 24 went on to 
attend the addiction counsellor. GPs also identified a range of improvements that could 
be implemented in order to improve the outcome of the letter as an intervention.  
A number of findings also emerged from the qualitative interviews with addiction 
counsellors and GPs, with both groups recognising that benzodiazepine addiction is a 
particularly challenging addiction to treat. Counsellors and GPs noted the effectiveness 
of the referral system in operation in the project.  A system of encouraging attendance 
had been adopted by both the counsellors and the practices themselves in terms of 
issuing reminders to clients and as a result very high attendance rates at the service were 
observed. The experience of integrating the counselling service within the practices was 
reported as very positive and complementary to each other’s services. There was also 
recognition of the importance of developing a range of strategies that can be employed 
as alternatives to prescribing benzodiazepines or which provide complementary supports 
1 By benzodiazepine use we are referring to all of these drugs.  The HSE Reports on Benzodiazepine 
Use (referred to on p14) does not include these ‘Z drugs’.
2  In a previous study Cormack et al (1994) had defined long term benzodiazepine use as patients 
who were“receiving at least one prescription for benzodiazepine every two months and had taken 
benzodiazepine continuously for at least six months”. The same definition of a long-term user of 
benzodiazepine was applied to this study. 
for those on benzodiazepines.
The project provided a tangible way of developing and fostering links in the 
community and promoted a multidisciplinary approach to the issue of drug use.  The 
recommendations in the report included the following:
• Addiction counselling services should be considered as an effective strategy to  
 complement existing general practitioner practices
• The use of a letter is an effective intervention in reducing benzodiazepine use
• The delivery of a counselling service as reported in this research should be   
 considered as a model for future pilot projects 
• Future research in this area should take into an account the client perspective and  
 feedback on the project.  
This project evolved from one that primarily envisaged meeting the needs of clients 
with a benzodiazepine addiction to one that now also has the ability to address other 
addiction issues that may present within a general practitioner setting. The findings and 
outcomes of this initiative have the potential to inform and influence the work of primary 
health care teams in Ballymun and beyond. The Ballymun Local Drugs Task Force will 









































































DESCRIPTION & CONTEXT OF PROJECT
2.1 Aims and Objectives 
The primary aim of the pilot project was to develop services for patients with 
benzodiazepine problems that present in primary care. The model proposed was that GPs 
in the practice would be supported by an addiction counsellor who would be integrated 
into each practice (approximately 10 hours in total per week). A key aspect of this 
proposal was the availability of the services of an addiction counsellor on site.  This free 
service for patients would allow for ease of access and seamless referral.
The objectives of the pilot programme were as follows:
• To help patients with a range of benzodiazepine problems
• To demonstrate the effectiveness of brief interventions in this area
• To prove that integrated team work (i.e. working with an addiction    
 counsellor within primary care) is an effective form of intervention
• To show that minimum training for GPs can develop skills that are helpful to   
 patients and their families
 
The project provided a valuable opportunity to increase the role of the general 
practitioners in the management and treatment of benzodiazepine use in Ballymun. 
2.2 Main Project Elements 
Some of the key features of the Project included; 
i. Counsellor on site-located at a primary care level, which would deal with   
 substance misuse issues around benzodiazepines 
ii. Easy referral to a counsellor which is discreet and operates within a team approach 
iii. A set number of hours of counselling available per week to each practice 
iv. Training on Motivational Interviewing provided for GPs
v. Research element incorporated into the project. 
2.3 Location of Project 
This new initiative was located in the new Ballymun Health Centre and was integrated 
within the overall provision of a range of other services in the Centre. The Project is 
managed by the Ballymun Family Practice and funded by the Local Drugs Task Force. 
Ballymun Family Practice consists of four separate surgeries/practices. 
These four practices in Ballymun were among the first to take part in the pilot primary 
care teams (PCT) set up nationally in 2005. The four practices cater to a patient 
population of approximately 10,000 - 12,000. The Ballymun Primary Care Pilot was 
established as one of the 10 national projects to develop a model of primary care service 
delivery as outlined in the Primary Care Strategy: Primary Care - A New Direction (2001). 
The PCT was set up to meet the needs of the emerging profile of Ballymun, a population 
with extremely high health and social needs. It is now well established and all four 
surgeries work closely as part of this team. The PCT is situated in the new Health Care 
Centre which was opened in 2006 and is located within the Civic Centre in Ballymun. This 
locates local primary care and some relevant network services in the one location. This 
integrated approach to primary care included the establishment of a multi disciplinary 
team which included GPs, psychiatric and public health nurses, physiotherapists, 
occupational therapists, speech and language therapists, social workers, dieticians and 



























The four general practices that make up the Ballymun Family Practice took part in 
this project. The GPs at the Ballymun Family Practice, previous to the establishment 
of the project, had worked in a complementary fashion with existing drug services in 
the area. GPs had also collaborated with, shared information and provided input on 
other activities/projects of the Ballymun Local Drugs Task Force (BLDTF). In this regard, 
the implementation of the GP-Community Partnership Addiction Project was a very 
appropriate development which further enhanced this working relationship.
2.4 Development of Project
The addiction counselling service began in the Ballymun Family Practice in September 
2006.  The service started with counselling being provided for 9 hours per week.  The 
amount of hours has varied as the service continued and has expanded.  In 2010 
the average hours of counselling per week was between 10-12 hours. On Tuesdays, 
for example, the counsellor generally meets clients from 9.30am-2.30pm while on 
Wednesday clients arrive for their sessions between 7.30am and 12.30pm – this earlier 
start is to facilitate clients who attend the methadone scripting/GP clinic.
The research undertaken and incorporated into the project had four main aims.  It sought 
to:
i. Document the addition of an addiction counselling service to a busy GP practice
ii. Obtain the counsellors and GPs’ views on benzodiazepine use in the community
iii. Detail and document the complexities involves in benzodiazepine prescribing and  
 addiction
iv. Determine quantitatively whether the offer of addiction counselling has additional  
 benefits in the reduction of benzodiazepine use when added to a standardised  
 letter sent to long-term users of benzodiazepines.
2.5 Background and Context 
This GP-Community Partnership Addiction Project was developed as a response 
to a study published by the Ballymun Youth Action Project (BYAP) in 2004 entitled 
Benzodiazepines – Whose Little Helper?- The role of benzodiazepines in the development 
of substance misuse problems in Ballymun. The report (2004: 40-43) highlighted that 
‘within Ballymun there is a generalized acceptance of benzodiazepines’ and that this 
‘normalization’ of benzodiazepine use can have immense consequences not only for the 
individuals concerned but for their families and the wider community. The research also 
suggested that ‘focusing attention primarily on doctor’s clinical decisions is only a partial 
response to the situation’ and that the ‘restriction of prescribing practice alone will not 
address the psychosocial issues, and is likely to create additional patient trauma’. One of 
the main findings that provided the impetus for seeking funding for the development of 
the project can be captured from the following quote contained in the report:
The “medicalisation” of this reality does not seem appropriate. Other interventions, 
whether individual or structural, designed to address the levels of experienced stress 
need to be fostered and used. 
(2004: 40)
 
Relevant recommendations from the study (2004: 45) included the following:
• That the patterns of benzodiazepine prescribing in Ballymun and elsewhere  
 in Ireland be examined.  This would entail a closer examination of prescribing   
 practice, including duration, review procedures, dosage and drug.
• That there is investment in the development of services to complement medical  
 practitioners. In particular, it was noted that there was a need to develop non-  
 pharmaceutical alternatives to benzodiazepine therapy.







































































 understanding of the role that benzodiazepines play in Ballymun.  It is also   
 hoped that, in the spirit of the community based research approach, it will   
 enable all stakeholders to gain insight and identify strategies which will contribute  
 to effective change.  
Following completion of BYAP research on the role of benzodiazepines in Ballymun, two 
follow-up meetings of local practitioners were convened in early 2005. The main aim 
of the meetings was to explore alternative responses to some of the issues identified in 
the research Whose Little Helper? During one meeting, it was noted that the recent work 
undertaken by Rolande Anderson of the Irish College of General Practitioners (ICGP) in 
the area of alcohol could provide a useful template for the development of services to 
complement GP practices in the area of benzodiazepines. At that time, the Local Drugs 
Task Force had access to the Emerging Needs Fund under the National Drug Strategy 
(2001-2008). This initiative fell under actions 41 and 39 of the National Drugs Strategy 
and in addition related to recommendation 8 of the Report of the Benzodiazepine 
Committee as detailed below; 
Action No. 41- To oversee the implementation of the recommendations of the 
Benzodiazepine Working Group, which is due to complete its work by the end of June 
2001 as part of the overall strategy of quality improvement of current services. 
(National Drug Strategy 2001-2008)
Action No. 39- To ensure that adequate training for health care and other 
professionals engaged in the management of drug dependency is available, including, 
if necessary, arrangements with third level institutions and professional bodies. 
(National Drug Strategy 2001-2008)  
Recommendation No.8- “where possible alternative therapies to the prescribing of 
benzodiazepines should be considered by clinicians. 
(Report of the Benzodiazepine Committee, 2002: 42). 
More recently, as part of the review of the Methadone Treatment Protocol in 2010, the 
issue of improving the standards of prescribing benzodiazepines was recommended as 
an immediate action to help reduce poor benzodiazepine prescribing practice across all 
sectors of services in the HSE. In this regard, the report The Introduction of the Opioid 
Treatment Protocol (2010) refers to the need for the implementation of recommendation 
10 from the report of the Benzodiazepine Committee (2002) which states:
Clinic doctors should communicate with clients’ general practitioners involved in 
the treatment of drug misusers regarding the prescribing of benzodiazepines. In 
most cases the clinic should, with the agreement of the general practitioner, take 
responsibility for the prescribing of benzodiazepines and so prevent double or  
multi-prescribing to known drug users. 
(2010: 34)  
2.6 Benzodiazepine Use and Ballymun
There are two groups of benzodiazepines- the ‘anxiolytics’ which are prescribed for 
anxiety and mild depression, and the ‘hypnotics’ which are prescribed for insomnia 
(severe sleep problems). Some of the common drugs within these categories include 
diazepam, temazepam and flurazepam (O’Mahony Carey, 2008). Benzodiazepines are in 
the depressant drug category, however when mixed with other ‘downers’, for example 



























In 2010, the Health Research Board published an overview of problem benzodiazepine 
use in Ireland from the period 1998-2007 (with data on treatment from 2003-2008 and 
deaths from 1998-2007). In the years from 2003-2008 the annual number of treated 
cases reporting  benzodiazepine as a problem substance increased by just over 63% 
from 1,054 in 2003 to 1,719 in 2008 (2010: 1-3). This research highlighted that there are 
higher numbers reporting benzodiazepines as an additional problem drug, but there was 
a bigger increase among those who reported benzodiazepines as their main problem 
drug. In terms of deaths attributed to benzodiazepine use in Ireland, they accounted 
for 31% of all deaths by poisoning recorded for the ten-year period (as recorded by the 
National Drug-Related Deaths Index). The annual number of deaths in 2007 in which 
benzodiazepines were implicated was 88 cases, with previous years also remaining 
consistently high (Bellerose et al: 2010). 
Quigley (2001: 331) acknowledges the legacy that benzodiazepine has had and notes 
that benzodiazepines, originally developed as a safer alternative to barbiturates have 
‘become a mainstay of medical practice over the last three decades’ . Therapeutic uses of 
benzodiazepines include treatment for sleep disorders, anxiety, depression and assisting 
people in coping with difficult situations such as bereavement.  While benzodiazepines 
are among the most widely prescribed drugs in the western world, a number of concerns 
have been raised about their use, such as the risk of developing dependence, risk of 
accident, cognitive impairment and abuse of benzodiazepines particularly among drug 
users (Quigley: 2001).  In 2000 Michéal Martin, then Minister of Health, established 
the Benzodiazepine Committee, which was designed to address inappropriate use of 
benzodiazepines. The Report of the Benzodiazepine Committee (2002) noted that while 
there were many benefits to benzodiazepine use, many of the negatives associated 
with its use were the result of inappropriate long-term use. It found that there were still 
many long-term prescribed benzodiazepine users in Ireland and suggested that ‘it would 
appear that in many cases the prescribing of these drugs is excessive and perhaps has 
become a matter of routine’ (p6). The Report also presented a study, undertaken by 
the Eastern Regional Health Authority that examined General Medical Services Scheme 
(GMS) data on benzodiazepine prescriptions during 1999-2000 in the EHRA area. The 
study revealed that benzodiazepines were being prescribed to approximately one in ten 
persons overall, up to one in five older people, and their use was higher among females 
than males. A study by William Teljeur, Bennett and Kelly (2003) noted that with an 
increase in deprivation, prescription rates for some drugs increased and others decreased; 
they concluded that benzodiazepine use increased with deprivation.3  
2.7 Prevalence of Use in Ballymun 
Ballymun Youth Action Project (2004:30-33) identified some key findings from an 
investigation of benzodiazepine dispensing patterns in Ballymun using community 
pharmacy-based dispensing records. 
 ▪ The total number of instances of tablet dispensing over 4 one-week periods   
 totalled 751 with no significant change observed across time.
 ▪ The majority were issued free of charge under the GMS scheme 
 ▪ 40 doctors had prescribed tablets, however 77% of all prescription items studied  
 across these time periods were written by 4 doctors. 
 ▪ Two thirds of prescriptions were dispensed to females and one third to males
 ▪ Diazepam as the most common drug dispensed followed by flurazepam. 
 ▪ Time since first record of benzodiazepine dispensing for almost two fifths of the  
 population (39%) was 5 years or more. 
**The findings refer to a retrospective study of the prescriptions for benzodiazepines that 
3 Chapter Five reports on a focus group with GPs at the commencement of the project in which GPs 







































































were dispensed in a small number of pharmacies over four separate one week periods from 
December 2000 and July 2002 (2004: 30)
More recently in 2006/2007, Ballymun Local Drugs Task Force undertook a local 
household prevalence study among the Ballymun population aged between 15-64 years. 
This was a booster sample that could be comparatively analysed against the national 
population. The findings highlight that in 2006/2007 Ballymun figures for sedatives and 
tranquillisers were comparatively higher than that within the national population. 
Table 1 Prevalence of Sedatives, Tranquillisers and Anti-depressants use in 
Ballymun and Nationally 
All Adults 15-64 years
Ballymun NRDTF* NACD**
Sedatives/Tranquillisers
Lifetime (Ever) 13.6 11.3 10.5
Recent (Last Year) 8.6 4.1 4.7
Current (Last Month) 7.6 2.3 3
Anti-Depressants
Lifetime (Ever) 10.6 9.6 9.2
Recent (Last Year) 4.0 3.8 4.3
Current (Last Month) 3.3 3 3.1
*North Regional Drugs Task Force Area (includes 5 Local Drugs Task Force areas)
** National Advisory Committee on Drugs (national figure) 
Source: NACD (2008) Drug Use in Ireland and Northern Ireland 2006/2007): Bulletin 2 and 
BLDTF, Local Household Prevalence Data 2006/2007
2.8 Benzodiazepine prescribing within the GP practices
In July 2007, all four GP practices that make up the Ballymun Family Practice had 
computerised their records.  It should be noted that there are two administrative centres 
within the Ballymun Family Practice and for ease of reporting through this research 
Practice 1 and 2 are used to refer to the practices downstairs and upstairs respectively.  
This meant that a GP Benzodiazepine Report for each GP working in the practice could 
be generated.  These HSE reports allow prescription rates from individual GPs to be seen 
in the context of national prescription rates.  The BYAP research findings suggested that 
‘the level of benzodiazepine prescribing in Ballymun today may be notably higher than 
the national level’ (2004: 8).  However it should be noted that one of the focus groups 
which was conducted as part of the BYAP 2004 research did indicate that prescribing in 
the GP practices in the Health Centre is “tight” (p 25).  This observation suggests a belief 
among participants in that research that the practices in the Centre were not providing 
unnecessary access to benzodiazepines.  The HSE reports, which display individual 
GP prescription rates for benzodiazepines seems to support this belief for example in 
October 2009 Practice 1, GP 1 and Practice 2, GP 1 had prescription rates of 43% and 9% 
respectively below the national rate. 




























STUDY DESIGN & METHODOLOGY
3.1 Research Design
A journal article that featured in the British Journal of General Practice heavily influenced 
the initial planning of the research phase of this project.  The article, written by Cormack, 
Sweeney, Hughes-Jones and Foot (1994:5) detailed the evaluation of ‘an easy, cost-
effective strategy for cutting benzodiazepine use in general practice’.  The aim of that 
study was to assess the effectiveness of a letter from a GP suggesting a reduction in 
the use of benzodiazepines, and whether the impact of the letter could be increased 
by the addition of information on how to tackle drug reduction.  While their study 
was used a model for the quantitative element of the research, there were significant 
differences; most notably the fact that instead of providing more information on reducing 
benzodiazepine, this study offered the services of an addiction counsellor, and secondly, 
while the 1994 study was purely quantitative, this research added a qualitative element 
through focus groups and in-depth interviews with GPs and addiction counsellors. 4 
A mixed method approach, in which both quantitative and qualitative methods were 
used, was adopted for this research. The methods used in this study were:
• Qualitative research using focus groups and in-depth interviews 
• Quantitative analysis of prescriptions of benzodiazepine
The use of mixed methods has become increasingly popular in recent years (Bryman, 
2006). Greene, Caracelli and Graham (1989) identified five purposes for mixed method 
evaluations: triangulation, complementarity, development, initiation and expansion. The 
rationale for the research design in this project was complementarity in that it was hoped 
that the results from one method could elaborate and enhance the results from the 
other.  Although statistics of prescription rates may explain part of the picture, it cannot 
tell the whole story. The study Benzodiazpines, Whose Little Helper?, which was referred 
to in Chapter Two (BYAP, 2004) acknowledged, for example, that swapping and sharing of 
benzodiazepines seemed to be a frequent occurrence in the area and they also argued 
that the prescribing practices of doctors did play a contributory role in the normalising 
of benzodiazepine use. By using a qualitative approach using focus groups with GPs 
and in-depth interviews with the addiction counsellors in combination with quantitative 
research, it was hoped that a more holistic picture would emerge.
3.2 Quantitative Research
The findings of the BYAP (2004) research suggested that the level of benzodiazepine 
prescribing in Ballymun was notably higher than the national level. They also indicated 
that a considerable proportion of patients who are initiated on benzodiazepines continue 
to take them for many years. Consequently they recommended that the patterns of 
benzodiazepine prescribing in Ballymun and elsewhere in Ireland be examined.  With this 
in mind, and in order to provide some statistical data on the impact of the intervention 
of a letter, a quantitative aspect of the research design was included in this research. 
Quantitative data was generated by monitoring benzodiazepine prescriptions of long-
term benzodiazepine users one year before they were sent the letter and six months 
afterwards.  A full analysis of the data generated can be seen in Chapter Four.
4 The Cormack et al study (1994) also included a control group of patients in their research.  It should 
also be noted that their study was building on an earlier British based study which was smaller in 
scale but which had found that a letter from a GP advising patients to cut down of their drugs was as 







































































3.2.1 Aim of Quantitative Dimension of Project
The quantitative aspect to this project aimed to determine whether the offer of 
the services of an addiction counsellor had additional benefit in the reduction of 
benzodiazepine use when added to a standardised letter sent to long-term users of 
benzodiazepines.  Essentially two interventions were evaluated: a letter inviting patients 
to reduce their intake (sent to Group 1) and a letter inviting patients to reduce and to 
avail of the services of an addiction counsellor (sent to Group 2).  In 2000 the Ballymun 
Local Drugs Task Force, in their Revised Action Plan noted that benzodiazepine use was 
impeding progress for those on methadone maintenance programmes. As such it was 
decided to send methadone protocol patients the same letter as was sent to group 2 
patients. 
There are four practices currently operating in the Ballymun Health Centre under 
the umbrella term Ballymun Family Practice. Initially it was estimated that there were 
approximately 400 patients that would meet the criteria to be included in the study – 
details of the criteria applied can be seen in the following section. Long term users of 
benzodiazepines, who met the criteria of the study, were randomised into Group 1 and 
Group 2 with methadone protocol patients treated as a separate group who were not 
randomised but placed directly into Group 2. Effectively this cohort can be seen as a 
third group (Group 3) with the rationale for this decision influenced by both ethical and 
pragmatic reasons.  Group 1 were sent a letter inviting them to reduce their intake of 
benzodiazepine while Group 2 were sent a letter asking them to reduce their intake and 
inviting them to avail of the services of an addiction counsellor. For the purposes of this 
study, results for Group 3 will be presented separately. It should be noted that all patients 
were not attributed to groups together but by practice – this meant that each practice 
had patients in each group. 
There are two administrative centres in the Ballymun Family Practice and for ease of 
reporting Practice 1 and 2 are used to refer to the practices downstairs and upstairs in the 
Health Centre respectively. For ethical reasons, the services of the addiction counsellor 
were available to all patients regardless as to whether they had received a letter or not.
The letter used by Cormack et al (1994) served as a model and the final versions, (see 
appendix B and C) which were literacy proofed, were approved by the Royal College of 
Surgeons in Ireland (RCSI) Research Ethics committee. 
3.2.2 Sample and Definition of Long-Term Benzodiazepine Use
In a previous study Cormack et al (1994) had defined long term benzodiazepine use as 
patients who were:
“receiving at least one prescription for benzodiazepine every two months and had taken 
benzodiazepine continuously for at least six months”.  
The same definition of a long-term user of benzodiazepine was applied to this study. 
The inclusion criteria for the study were patients over 18 years of age who were long 
terms users of benzodiazepines. Patients whose benzodiazepine use was sourced 
through psychiatric services were excluded from the research.  It was agreed that alcohol 
dependency was not a reason for exclusion due to the fact that benzodiazepine use may 
mask alcohol dependency. GPs were asked to identify from their records long-term users 
of benzodiazepines who fitted the criteria and the relevant letters were dispatched.
It is important to note that the drugs which were counted as part of the study included 
benzodiazepines such as  Alprazolam (Xanax), Bromazepam (Lexotan) Chlordiazepoxide 
(Librium), Diazepam (Anxicalm, Valium) Flurazepam (Dalmane) Flunitrazepam (Rohypnol), 



























included as part of the list were drugs that are colloquially known as ‘Z drugs’.  These 
drugs while chemically different from benzodiazepines have the same effects on the 
body and act by the same mechanisms.  The Z drugs that were counted were Zaleplon 
(Sonata), Zolpidem (Stilnoct), Zopiclone (Zimovane, Zopitan, Zileze).5
3.2.3 Characteristics of Sample
Table 2 highlights the age and gender profile of the sample per GP practice. This ratio of 
almost three females for every male was in line with research from BYAP (2004), which 
noted that whilst benzodiazepine use was found to occur among all age groups, more 
women than men were found to use them.  
Table 2 Characteristics of the Sample
Characteristics of the sample from Practice and Group Perspective
Practice 1 Practice 2
Group 1 Group 2 Group 1 Group 2
Median Age: 61 57.5 61 44.50
Mean Age: 60 54.24 55.33 47.85
No. who are also on methadone protocol 2 22
No. of females: 26 22 13 39
No. of males: 7 4 8 15
As can be seen from Table 2, Group 2 in Practice 2 has a much younger profile.  This 
may be attributed to the fact that Practice 2 has a much higher proportion of long 
term benzodiazepine users, who met the criteria of the study and who are also on the 
methadone maintenance programme (n=22) as compared to practice 1 (n=2).  This 
cohort seemed to merit closer analysis. 
Cohort on Methadone Maintenance Programme
One key difference between the two practices is the number of long-term users of 
benzodiazepine who are also on methadone – this difference became apparent when 
comparing the age profiles of each practice. The average age of Group 2 in Practice 2 
for example is 47.85 compared to 54.81 in Practice 1.  However if we remove those on 
methadone maintenance from Group 2 in Practice 2, the average age is 56.56 which is 
much closer to Practice 1. 
In order to explore the data further, this cohort was extracted from both Practice 1 and 2 
and broken down in terms of age and gender.  Table 3 illustrates these results:
Table 3: Profile of Patients on Methadone Maintenance






Ratio of male: female 1:2
Overall, 134 patients were sent a letter by post; 54 were placed in Group 1 and sent a 
letter inviting them to consider reducing benzodiazepines, whilst 80 (24 of whom were 
5 By benzodiazepine use we are referring to all of these drugs.  The HSE Reports on Benzodiazepine 







































































availing of the methadone maintenance programme) were placed in Group 2 and sent 
a letter inviting them to consider reducing benzodiazepines and alerting them to the 
services of an addiction counsellor.
3.3 Qualitative Research
Focus Groups with GPs
The study by BYAP on benzodiazepine use in Ballymun (2004) indicated that the level of 
benzodiazepine prescribing in Ballymun is comparably higher than the national average. 
All groups interviewed in that research study identified prescribing by doctors as one of 
the sources of their benzodiazepine use. The prescribing of benzodiazepines has been 
described as “a complex cultural and social process with political, economic, moral as well 
as medico-social implications” (Clare, 1991, p187). With this in mind, a focus group with 
GPs took place before the project began.  One of the key advantages of a focus group is 
that it can provide extremely rich data as it allows participants to respond to each other’s 
views and discuss the differences or similarities with their experiences. Bloor, Frankland, 
Thomas and Robson (2001) acknowledge the usefulness of focus groups in terms of 
both complementing other methods in a multi-method study and providing contextual 
information as well as an interpretative aid to quantitative findings.  Five GPs took part 
in the focus group and the focus group provided the opportunity to hear GPs’ views 
on benzo use, their experience of prescribing benzos and their expectations of how a 
counselling service would work.  The interview schedule used in this focus group can be 
seen in Appendix A.  
In autumn 2009 near the completion of the project, a follow up focus group with GPs 
took place.  This focus group, taking place three years later than the initial focus group, 
allowed GPs to give their reflections on how the addition of an addiction counsellor had 
worked in practice, whether their initial concerns and expectations about the project 
were realised and how they felt about the research undertaken and suggestions for 
improvements.  This focus group provided valuable insights and Chapter Five describes 
the findings in more detail.  The interview schedule used for this follow up focus group 
can be seen in Appendix E.
In-depth Interviews with Addiction Counsellors
Semi-structured interviews with two addiction counsellors took place in June 2009.6  
One counsellor was interviewed over the phone and one on-site at the GP practice. The 
interview schedule used in the interviews can be seen in Appendix D.  Similar to focus 
groups, semi-structured or in-depth interviews offer a number of advantages including 
the depth of information and insights provided and validity (Denscombe, 2003). 
A full discussion of findings from the interviews and the focus group can be found in 
Chapter Five.
3.4 Data Collection
As mentioned above, a focus group was held with GPs at the onset of the research.  
GPs were also asked to identify long-term users of benzodiazepine and from this list, 
patients were allocated groups and sent the relevant letter inviting them to reduce their 
use of benzodiazepine.  This did not commence until ethical approval was given by the 
RCSI. Practice 1 compiled their list first and letters were sent in May 2007, while letters 
from Practice 2 were sent in April 2008.  Data collection was ongoing throughout 2007 
and 2008.  During the project in-depth interviews with the addiction counsellor were 
conducted and a focus group with GPs took place at the end of the research.
6 Since the commencement of the GP Community Addiction Project 3 counsellors, have spent varying 




























The following chart illustrates the timeline of the research
Summer 06   Sept 06 May 07   April 08 June 2009 September 2009
3.5 Data Analysis
The qualitative interviews were transcribed and read a number of times by two researchers 
who independently identified a number of themes.  Once the themes were identified and 
agreed (by both), the interviews were analysed again and coded.
The quantitative data was analysed using Excel and is descriptive and exploratory only 
with further data needed to provide more sophisticated analysis.
3.6 Limitations
It is hoped that this small-scale research project will provide a holistic picture of the 
complexities of benzodiazepine prescribing and addiction.  However, it is important to 
acknowledge the limitations of the research.
• The quantitative data is based on prescriptions of benzodiazepines only. Measuring 
 prescription rates is in itself quite a crude measurement in the sense that it does  
 not take into account that not all medication may be consumed by the patient.
• Although the views of GPs and addiction counsellors were sought in this research,  
 no clients were consulted.  It is suggested that future research should include   




























































































LETTER AS A BRIEF INTERVENTION TOOL
4.1 Introduction
As detailed in the previous chapter, this element of the project aimed to determine 
whether the offer of the services of an addiction counsellor had additional benefits in the 
reduction of benzodiazepine use when added to a standardised letter sent to long-term 
users of benzodiazepines.  Essentially two interventions were evaluated: a letter inviting 
patients to reduce their intake (sent to Group 1) and a letter inviting patients to reduce 
and to avail of the services of an addiction counsellor (sent to Group 2).  Long terms users 
of benzodiazepines who were also methadone protocol patients were sent the same letter 
as Group 2 patients (Group 3). 
At the commencement of the project, GPs anticipated that the number of long-term 
benzodiazepine users that would qualify for inclusion in the study would be in the 
region of 400.  This proved to be an over-estimation. Originally, from 158 patients 
listed, a number were not included in the sample for a variety of reasons including 
misidentification, imprisonment, death and serious illness. The final sample consisted of 
134 people, 100 females and 34 males.
4.2 Establishing Baseline Benzodiazepine Use
Both Gorgels et al (2005) and Cormack et al (1994) convert prescribed benzodiazepines 
into diazepam equivalents with Cormack et al. treating 5mg Diazepam as one tablet – see 
Appendix F for more details of the conversions used. The method used by Cormack et al. 
in establishing baseline data of benzodiazepine was influential in this study; and as with 
Cormack et al’s study baseline data was generated by monitoring prescriptions issued 
to patients a year prior to the letter being sent then dividing the total number of tablet 
equivalents by two. By considering one year, any seasonal variations could be avoided.  
Prescriptions issued to all groups were monitored.
However Cormack et al’s study used much more sophisticated statistical analysis and 
differed from the present study in a number of key ways:
• In order to evaluate the effect of the interventions on benzodiazepine consumption 
 the number of tablet equivalents taken in the monitoring period was divided by  
 the number taken during the baseline period for each patient in the study and then  
 t-tests were performed to determine whether one intervention was more effective  
 than the other.  The present study however compares the six month period post  
 letter being sent with the baseline data only.
• Cormac et al’s study used advice from a pharmacist to calculate consumption of 
 benzodiazepines based on prescriptions issued before the beginning of the   
 baseline period and before the end of the monitoring period. The study also   
 created a second baseline by measuring benzodiazepine use six months before  
 the letter being sent in order to analyse patters of benzodiazepine use prior to the  
 intervention – this was not done in this study.
As can be seen from above, Cormac et al’s study was able to provide much more 
sophisticated analysis whereas the analysis in the present study is exploratory.  However 



























4.3 Results and Discussion
In Group 1 patients were sent a letter advising them to consider their current 
benzodiazepine use. In monitoring this group’s benzodiazepine use six months post 
the letter being sent) 16 people did decrease their benzodiazepine use and the average 
decrease was 133.59 tablets (with each tablet the equivalent of 5mg of diazepam). Table 4 
details the age and gender profile of patients who did decrease their benzodiazepine use.








As a % of Group 29%
It is worth noting that 54 patients were in Group 1, which means that just over 29% of 
patients decreased their benzodiazepine use.  For some patients the letter seemed to have 
no effect although it should be noted that medical notes reveal that a number of patients 
did bring up the subject of the letter if only to explain that reducing was not an option for 
them at present.7
If we examine Group 2 (the group who received a letter asking them to consider their 
benzodiazepine use and offering the services of a counsellor) we can see that there seems 
to have been more success with this intervention. 
Table 5 shows that out of 80 patients who were placed in this group, 31 (over 38%) 
reduced their prescription for benzodiazepines.








As a % of Group 38%
 In order to get a more in-depth picture, the data from those who were availing of 
methadone maintenance were extracted.  Table 6 indicates the results from this cohort 
(n= 24) who placed in Group 2 and who were also on the methadone maintenance 
programme.
7 This measure should be considered as a crude indicator only, GPs were not asked to record whether 
patients mentioned they had they received this letter.  Medical notes however do reveal 15 patients out 















































































As a % of Group 37.5%
As can be seen from Table 6, nine out of twenty-four from this cohort (37.5%) reduced 
their benzodiazepine use.  Indeed in further analysis of appointments with the addiction 
counsellor (January 2007-December 2010), it was discovered that six out of the twenty-
four (25%) in this Group 3 cohort had availed of the counselling service. 8











Group 1 33 60 10 30.3
Group 2 (incl. 
methadone 
maintenance patients)
24 54.24 11 45.83
Group 3 (methadone 
maintenance only)
2 46.5 2 100
Practice 
2
Group 1 21 61 6 28.57
Group 2 (incl. 
methadone 
maintenance patients)
32 44.5 11 34.37
Group 3 (methadone 
maintenance only)
22 34.84 7 31.81
4.4 Suggested Improvements to the Letter as a Brief Intervention Tool
The focus group with GPs, which took place towards the end of the project, identified a 
number of key ways that the project could be improved upon with particular regard to the 
sending out of letters.  In this second focus group GPs were asked about what impact, if 
any, they thought the letter had.  Most GPs were not optimistic about how effective the 
letter itself had been with one GP (Practice 2, GP4) reporting no one mentioning the letter 
and others reported feeling that it had only a very limited response.
I’d only about six patients mention the letter to me, and they all came to justify how 
they couldn’t possibly reduce and were a little bit, not offended by the letter but 
felt they needed to justify and no one took up, I think one took up the offer of the 
counselling, and then no one else even mentioned that they got it
(PRACTICE 1, GP1)
8 In comparison, only one person from Group 1 availed of the counselling service and none from Group    
2 excluding methadone protocol patients.The results from Group 2 are noteworthy as this group (as 
with Group 3) received a letter explicitly inviting them to avail of the addiction counselling service; the 
differences between groups underlines the complexities of benzodiazepine use and  is explored further 



























Another GP commented on the difference between results in this study and the one 
that had been so successful in England there’s something different in the culture and 
the health beliefs here.
(PRACTICE 2, GP1)
In practice however, the results seem to be more positive than what the GPs perceived. 
There is an interesting parallel here with the fact that at the beginning of the study GPs 
overestimated the number of long-terms users in their practice which suggests perhaps 
that in the day-to-day work of a busy practice it may be difficult to get a full picture of 
what is occurring.
A number of practical improvements were suggested including:
1. Using shorter letters
2. More awareness of literacy considerations
3. Personally handing out letters rather than posting them
One GP felt that the letter was long and would not be of the usual length she would send 
to patients.  Another stated the letter might be difficult for some patients to read. Another 
GP felt that in their practice they had discovered that posting letters simply didn’t work 
and while the GP felt that this could be caused by postal difficulties in an area undergoing 
regeneration he also felt that
 Letters aren’t taken particularly seriously here.
(PRACTICE 2, GP1)
GPs agreed that letters posted out did not seem to work.
Here a lot of the time, letters could mean trouble.
(PRACTICE 2, GP4)
Official looking things aren’t viewed pleasantly.
(PRACTICE 1, GP1)
An important insight in the final focus group with GPs was the value of finding out what 
actually works in a local context. Written communication with patients is a common 
feature of health care however it was clear from the focus group that what does seem to 
work are letters handed to patients with their prescriptions.
I mean what does work is actually handing them out with the prescriptions and I 
think in future that might be worthwhile doing something like that, because you know 
letters for the, […] asking people to come in and have their medication reviewed, they 
tend to, by and large, recognise that, come in for their appointments, not always now 
but a lot of them do, so that we give someone a prescription, quite often we attach a 
letter saying, you need a medication review please make an appointment to see us 
before your next prescription and they will come in to see us, so but that’s handed by 
the receptionist.
(PRACTICE 2, GP1)
Overall, despite the challenges that the project presented, there was overwhelming 
agreement that it was a positive development for all those who participated.








































































4.5 Summary of Main Points of the Effectiveness of a Letter as a Brief 
Intervention 
• GPs overestimated the number of long-term users of benzodiazepines who fitted  
 the criteria of the study.
• One surgery had more patients availing of methadone maintenance than the other  
 which indicates that the profile of patients in each practice is different.
• Analysis of the sample of long-term benzodiazepine users did reveal a younger  
 cohort who were also on the methadone maintenance programme.
• In line with other research, more women than men were identified as long-term  
 users of benzodiazepines.
• The brief intervention of a standard letter did result in decreases in some   
 prescription rates.
• The brief intervention of a letter with the offer of the services of an addiction   
 counsellor did also result in decreases in some prescription rates.
• The decrease was particularly noticeable in the cohort who also availed of   
 methadone maintenance treatment.
• GPs identified a range of improvements that could be implemented in order to  
 improve the outcome of the letter as an intervention.  Those improvements   
 included: using a shorter letter, more literacy awareness and personally handing  




























FINDINGS FROM INTERVIEWS/FOCUS GROUPS 
WITH GPs & ADDICTION COUNSELLORS
5.1 Introduction 
As highlighted in the methodology chapter, various interviews and focus groups were 
undertaken with GPs in the practices and addiction counsellors. The in-depth interviews 
with the addiction counsellors took place in the summer of 2009 following over two 
years of implementation of the service. In terms of gathering qualitative information from 
the GPs, the first focus group occurred in September 2006 at a time when the addiction 
counsellor had yet to be formally appointed.  The final focus group with GPs took place in 
October 2009 and by then an addiction counsellor had been integrated into the practice 
for over two years. This focus group allowed for reflection on the research project in 
general and the impact of the on-site counselling service in particular.  
A number of themes emerged including how benzodiazepine prescribing is managed 
in the practices, the perceived results of the project, how the referral process works, the 
integration of a counsellor within GP practices, issues and challenges that arose and 
suggestions for improvements.
5.2 The local context of benzodiazepine use
The historical context of benzodiazepine use in Ballymun came to the fore in the initial 
focus group with GPs with the feeling that benzodiazepine use was prevalent in the 
area. A number of GPs reported on their frustration of finding themselves in a situation 
where large numbers of people had been previously prescribed benzodiazepines and as 
a consequence a clear sense of expectation among patients had been established. Many 
times GPs referred to a culture of benzodiazepine use:
There’s a whole culture here, the culture here that people would have, would be 
that benzodiazepines are drugs that are used if they had a crisis or were anxious or 
depressed.
(Practice 2, GP1)
I think again what happened over the years was, you know, there would be a lot of 
people who would come in and they would be prescribed the benzos and they’re on 
them all the time and then because of the culture that’s here, you know, for any slight 
crisis or whatever, people would just come to the doctor looking for their benzos and… 
people think that they need that treatment for anything that goes wrong in their life.
(Practice 1, GP2)
Against this historical context of benzodiazepine prescribing, a number of GPs reported 
on the difficulties of having to manage people’s expectations and sense of entitlement 
to benzodiazepines.  One GP noted the persistence of some patients in relation to 
benzodiazepines and described a scenario in which long-term prescriptions may begin:
It’s the experience here that if somebody had decided that the treatment for what they 
are suffering is benzodiazepines then they will come back,  … they will come back and 
they will often keep coming back and because we’re a group practice they will see any 
one of a number of doctors, until they eventually find a doctor who will prescribe a 







































































 being continued. I think that’s how long-term prescriptions start.
(Practice 2, GP2)
5.3 The complexity of benzodiazepine use
Both addiction counsellors were aware of the complexities of benzodiazepine addiction, 
with one noting how quickly it can seem to develop:
It’s one of those, like, that can start off quite mild, sure within weeks, months, like you 
know it just seems to have spiralled out of control.
(Addiction Counsellor 2)
It was also felt by counsellors that benzodiazepine addiction was a particularly difficult 
addiction to deal with, one describing it as a slow process that was often one of the last 
addictions clients themselves tried to tackle.
I won’t say it’s kept hidden because you know, you can sense and you can see 
sometimes the way some people could present but it’s always the last piece to be 
mentioned you know when you take a little bit of a history particularly around 
somebody maybe who wants to, who might be interested in doing a methadone detox, 
and it’s when you start looking at ‘well is there any other medication, are you on 
prescribed medication’ and then you’re down to a seven day, ‘what have you used in 
the last seven days?’, you know and ‘I had a couple of sleepers’, but if you get to the 
couple of sleepers,  well it actually turns out to be a lot more than a couple of sleepers 
you know so it’s hard to kind of actually quantify it really.
(Addiction Counsellor 2)
There was overwhelming agreement that benzodiazepine use and its reduction is a 
complex area. A number of GPs had experience of a time when prescribing benzodiazepine 
was seen as a good thing and are now faced with a situation in which benzodiazepine 
prescription is seen in a negative light. One GP reported their frustration at how 
prescribing benzodiazepines is sometimes presented as a black and white area whereas 
they felt that the reality on the frontline was often much more complex than that. They 
noted that some medical professionals simply don’t prescribe benzodiazepines and live 
in an ‘ivory tower’ whereas this option was not open to GPs who were working on the 
ground.
There’s no guidelines it’s just a no or detox but there’s no sort of broad based approach 
and I would hope that by using an addiction counsellor and that we would have a 
more realistic approach for how we work in the community […] like the psychiatrists 
just won’t prescribe, they say no and walk away from it, but we don’t have the 
opportunity to do that, we have to live with it.  
(Practice 2, GP1)
There was an acknowledgement among the GPs that unprescribed benzodiazepine 
use was a problem.  One GP also noted that a holistic approach for dealing with 
benzodiazepine use is needed and that simply reducing its use or stopping prescriptions 
would not automatically solve the problem.
The benzodiazepine is only a symptom of something much greater you know, 
they’re not on it for fun and, so you know we’re not trying to belittle it and we could 





























5.3.1 Patterns of Prescription
In the focus group the GPs recounted strategies that have been in use in their practice 
such as having a system that controlled prescriptions for long-term users. These include 
dispensing for short periods of time and in small quantities. 
Anyone on chronic scripts never gets more than a month at a time and a lot of them 
[…] are on weekly dispensing so that it’s very controlled and there’s no dipping into 
them, and […] we would post date the script, you know if they ring before they’re 
actually due, we post-date them on the computer, so there’s no building them up, 
stockpiling, they’re literally only on the dose they’re on and there’s no hidden ways of 
getting more.  
(PRACTICE 1, GP1)
GPs referred to the Department of Health and Children’s booklet Benzodiazepines, Good 
Practice Guidelines for Clinicians which recommended phased dispensing and small 
quantities of prescriptions.
In that it says the best way of controlling it is small amounts at a time, regular 
dispensing arrangements.  And it does work definitely and you’d often say to a client 
look that has to be every week. So that you know, on a bad day, if there’s more tablets 
there you’re going to want them, so if you’ve only got seven tablets to last you seven 
days, you’re going to be less likely to dip in than if you’ve 28 tablets to last you four 
weeks, you now that kind of way, and it does make a difference definitely.
(PRACTICE 1, GP1)
One GP (PRACTICE 2, GP4) reiterated this and felt that almost without realising it, GPs in 
the practices had changed their way of prescribing in recent years.
5.3.2 Alternatives to Prescribing Benzodiazepine/ Training
GPs reported a number of strategies that they use as an alternative to prescribing 
benzodiazepines. Overall they recognised the importance of exploring all avenues in order 
to try to have a “coherent approach that makes sense and seems right” (Practice 2, GP1). 
The simplest strategy that was employed was to sit down and talk to the person and find 
out why they were anxious and looking for medication. 
We give time to people that are suffering from anxiety, we often give quite a lot of time 
over a period of time …. While we mightn’t consider ourselves trained counsellors we 
spend a lot of time counselling, talking to people.
 (PRACTICE 2, GP3)
Another alternative that was sometimes used was to cross refer to the community mental 
health services. 
We’re lucky now in that we have a psychologist and a community mental health nurse 
so that if someone is having anxiety and panic attacks, I quite often refer them to those 
avenues…. before they weren’t available and that’s one of the reasons why benzos 
were so widespread there were no resources available for people with you know major 
psychological problems, difficult lives, anxieties, panics.  
(PRACTICE 2, GP1)
GPs recognised the importance of training in different approaches as a means of 
dealing with current benzodiazepine use. This was despite varying experience of training 
received and practical application of the techniques of cognitive behavioural training and 







































































be able to “have something else to offer the person to do to help with their symptoms 
apart from taking a tablet”.
Overall, there was an acknowledgement among GPs of the effect of minimal interventions 
on long term benzodiazepine use. Other strategies used by GPs included providing 
relevant literature on how to deal with anxiety and also referring patients to appropriate 
websites that outline coping strategies and techniques for dealing with anxiety. 
5.4 Client Profile in Project
All GPs agreed that there was a diverse profile of benzodiazepine users in terms of age and 
gender with two distinct groups emerging. It became clear that one cohort were younger 
users, many of whom were also on methadone, while another cohort are elderly people 
who have been on benzodiazepines for a long time, some for over 30 years.  While some 
GPs questioned the harm of a very low dose of benzodiazepine over a number of years 
and the usefulness of asking this cohort to reduce; another felt strongly that this group 
should be included as she felt that very often they may not be using the benzodiazepines 
themselves but rather supplying them to family members.
I still think we’re right to invite them because […] you say how many of them are you 
actually taking? Ah one or two and son is getting a few and daddy getting and they’re 
going around the house and cousins and whoever kind of needs one, so I think we’re 
right to address the group, I don’t think they’re a crisis group and I don’t think they’re 
the major focus but they’re worth it.
(PRACTICE 1, GP1)
While one GP felt that in her experience there were a lot more women than men on 
benzodiazepines among elderly users another felt that there was no gender predominance 
in younger users.  Both addiction counsellors also reported a gender balance in terms of 
clients who attended.
5.5 Project Implementation
5.5.1 A Multi-Disciplinary Approach 
In 2002, the then Minister of Health, Michael Martin announced the approval of ten 
Primary Care Teams under the primary care strategy Primary Care – A New Direction 
(2002).  The four general practices in Ballymun who took part in this research were 
successful in becoming part of local Primary Care Teams.  This integrated approach to 
primary care included the establishment of a multidisciplinary team which included GPs, 
psychiatric and public health nurses, physiotherapists, occupational therapists, speech and 
language therapists, social workers and dieticians.
Both GPs and Addiction Counsellors in the course of this project commented on the 
benefits of working in a multi-disciplinary team. One addiction counsellor (1) noted that a 
team approach had huge benefits to clients dealing with addiction.  Another felt that this 
approach offered practical benefits to people.
It really is the way to go for the future, that everything is situated in one building, …
you know, that especially for young mums or people who might only be able to get 
out once or twice a week that if they want to go to their GP, they can actually visit the 
dietician as well, or they can go downstairs to a bit of physio or upstairs…
(Addiction Counsellor 2)
The integration of an addiction counselling service into a busy GP practice was not without 



























counsellors as will be further described. 
5.5.2 Flexibility
One of the key elements envisaged for the Project was that it would be flexible to clients’ 
circumstances and needs. The initial focus group with GPs clearly identified this as a 
crucially important concern.  One GP had experience of working in a drug clinic, which 
used a very structured model of counselling with one-to-one hour-long sessions being 
offered.  In their experience that type of model did not work and they felt that the idea of 
keeping appointments and sitting for an hour talking to one person about their addiction 
placed a huge demand on poly drug users who were usually living quite chaotic lives. 
I suppose I have some misgivings about the model of counselling that has a one-to-one 
one hour consultation with people because the people I was seeing in the drug clinic 
who are quite heavily addicted, poly drug users and often quite chaotic, that model did 
not work well.  That they were not able to keep appointments, they weren’t able to be 
in a room with another person, talking personally for an hour.
(PRACTICE 2, GP2)
There was general agreement among the GPs at the initial stage of this project that a new 
more flexible model needed to be created.  When advertising the position of addiction 
counsellor, one GP noted that even at that stage a key concern was to have a flexible 
model- ‘We were anxious not to prescribe the post’ (Practice 1, GP1). 
Instead the emphasis was on getting free thinking people who are able to evolve the 
position and create a model that might work and work closely with us that we can all 
amend it.
(PRACTICE 1, GP1)
5.5.3 Referral Process Employed 
GPs noted that patients could request a referral to see the addiction counsellor. However 
the most reported means of referral from GPs were as a result of discussions initiated by 
the GPs themselves.
Within such circumstances, different styles are used to engage clients. One doctor reported 
that they firstly highlight that a helpful person is present and can assist them when they 
feel like they want to talk about the issue. Even though the patient may wish to see the 
counsellor on site, one doctor reported that they may need to be helped through the 
steps of speaking to somebody. Another doctor refers to two or three very chaotic clients 
whereby it was sometimes necessary to have the “methadone script as the carrot” and that 
the script was ready for them to collect following their visit with the counsellor. According 
to the doctor this “has worked well”. 
The carrot could be maybe the week they see the counsellor they don’t have to see the 
doctor, […], they can do a urine but go, you know and there’s a prize, you know, there’s 
an incentive, you know you’re not double waiting, they might be an hour in the centre 
waiting to see us.
(PRACTICE 1, GP1)
The word “counsellor” was also reported as possibly being a less than useful word when 
trying to refer individuals to the service with one doctor noting, 
That there’s something about the word counsellor that people run from.
(PRACTICE 1, GP1)







































































make a referral to the counsellor. 
But, there would be a few people, I’m thinking of one, who is, he’s coming down off his 
methadone, he’s stopped it because he can’t cope any further, and he’s asked could he 
be referred to some counsellor to help get off it, so there would be a few who would do 
that.
(PRACTICE 2, GP1)
GPs and counsellors were both asked about the workings of the referral system and how 
effective they thought it was. The majority of the referrals to the counsellors came through 
either GPs or Project Workers. One of the main considerations in the development of the 
service was the importance of the counselling service to link in with, and refer to other 
drug related service and supports in the Ballymun area. Although described earlier as a 
“one stop shop”, the same counsellor noted the importance of not working in isolation and 
working with other external agencies for the benefit of the clients. 
It’s almost as if we can be self-sufficient, there’s no need to think we are because there’s 
so many other agencies and services so local, you know, all wanting and wishing the 
best for the clients and the people that walk through their doors you know and you can 
nearly feel it at times.
(Addiction Counsellor 2)
Feedback from both counsellors highlighted instances whereby they received referrals 
from agencies in Ballymun and situations that the counsellors referred out to agencies.   
Recently I had reason to refer to the De Paul trust.  I know it’s only a phone call away, 
in actual fact the building is only around the corner so you walk over with the referral, 
you meet the people and this is I suppose, this is the complementary thing, you know, 
that one service actually adds to another and how that service feeds back in like you 
know, so overall it does, you know I mean the complementary therapies, I know that 
YAP has its doors wide open for us so if there is somebody really stressed or wants a bit 
of relaxation you just have to lift phone and there’s always someone there ‘yeah sure 
send them over, we’ve a late night on such and such a night, there’ll somebody here, 
send them over’ 
(Addiction Counsellor 2)
Both counsellors expressed satisfaction with how the referral system operates.
I feel it works, I feel it works […] you know, the referral will be left in my cubby down 
there and when I get it I just date it, and it’s you know the date of the referral, the name 
of the GP who did the referral and a telephone number. And then as the list starts to 
roll, the referral is just taken out then and it’s processed in the usual way, so it’s taken 
off the waiting list and it’s put into the present clients that are attending for counselling 
and then when after six, eight, ten weeks or six months when the sessions are coming 
to an end, just remove it out of the file, and you put it in and it’s an easy way of 
keeping a tag on those who have finished up, or those who have gone on to treatment, 
those who have gone for detox, you know, it’s very easy to just look back in 
because it’s there sitting looking at you like.  
(Addiction Counsellor 2)
5.5.3.1 Impact of Training on Referral 
The training in motivational interviewing that the doctors received at the beginning of 
the Project was reported at follow-up to very clearly influence the nature and selection of 
referrals by the doctors to the counsellor.



























motivational interviewing, so I tend not to refer people now until they’ve reached a 
certain level of motivation and I wait until they’re ready whereas before I used to, it 
was sort of, I used to refer them much earlier.
(PRACTICE 2, GP3)
 
Similarly this doctor reported at follow-up how a referral to a counsellor was based more 
firmly on other elements apart from the need just to refer because a service is available.
Well that was because it was like ticking a box, it was like, I need to talk to somebody 
so go to counsellor, I think now I’ve an understanding of the need for motivation 
because it’s not just ticking a box, they have to be prepared to buy into it.
(PRACTICE 2, GP1)
All agreed that the motivational interviewing training was effective and that they would 
be positive towards obtaining further training and in particular they highlighted the 
importance of refresher training every few years. The training received was also reported 
to be helpful beyond the project in question. In particular, one doctor reported at follow-
up that it was beneficial in relation to all their consultations and “not just related to this 
group of clients” and that it was helpful “in dealing with our kids, and everything else, at 
every level” (Practice 2, GP3). One GP noted that improvements in the referral process had 
an impact on attendance levels. Similarly, the following quote highlights how the presence 
of a counsellor can contribute favourably to the criteria used and selection of referrals: 
 
I think one of the things about having a counsellor is that GPs are always 
psychologically minded you don’t get to general practice without being, but you’re even 
more psychologically minded when there’s a counsellor around and everything is done 
better and therefore I think the referrals are different.
(PRACTICE 2, GP3)
5.5.4 Attendance 
Both counsellors reported very good attendance rates at the service. Some clients would 
routinely come for appointments over a period of months while others would come for a 
number of sessions (sometimes just 5 or 6) when something was going on in their lives. 
I would have seen some people, yeah I would have actually, weeks not months, weeks, 
addiction takes a while to em to kind of get a grip of, like you’ve to build up a person in 
more than one way like you know, giving them confidence in their own way of dealing 
with things.
(Addiction Counsellor 1)
In terms of having a client contract in place, there were different approaches used by each 
counsellor. One had a formal contract that was provided to clients while the other included 
it as a discussion topic on a client’s first visit. However the issue of attendance was built in 
to the client contract/initial discussion.
Well, you’d, I’d always give, I’d always give them the contract when they come to 
see you, once they get this, if they can’t make the session they would phone, to the 
secretary at the desk and if they didn’t phone they’d get one chance and then they go 
down to the bottom of the list.
(Addiction Counsellor 1)
When I’d be meeting somebody for the first time I’d build it in as part of it, you know if 
you feel you can’t make an appointment or for whatever reason you can’t make it or 
don’t want to come in, just let me know, like there’s absolutely no consequences, if you 








































































It became clear through interviewing the counsellors that a sophisticated system to 
encourage attendance had been adopted by the practices as a whole. All clients, for 
example, are contacted by phone or text the day before their scheduled appointment with 
the counsellor and it was noted by the counsellors that the high attendance rates could 
have been influenced by the effort made by both the receptionist and counsellors in terms 
of sending out reminders to clients regarding their next appointment. 
Nine times out of ten, whoever confirms on the Wednesday will turn up, or whoever 
confirms on the Tuesday will turn up [….] It’s most unusual that someone will say ‘yes 
I’ll be there’ and it’s just no show, that’s most, most unusual.  
(Addiction Counsellor 2)
If there are two missed appointments with no explanation, the counsellor will ring on the 
third, if there is still no response that client’s appointment would then be given away that 
week to someone on the waiting list. 
5.6 Perceived Results of the Project
The first focus group revealed that GPs had clearly identified two cohorts of patients in 
relation to benzodiazepine use – an older group who had been on benzodiazpines for 
years and a second younger group who were on methadone.  Perceived results in relation 
to the success of the project where understood by GPs in relation to these two distinct 
groups. 
5.6.1 Older Cohort of very long term users of benzodiazepines
One cohort identified was an older one who had been on benzodiazepines for years. For 
this older cohort the project was felt in general to have made very little difference.
I didn’t find they wanted the engagement of an addiction counsellor, I didn’t 
particularly feel they needed it in their day to day life and they had no particular wish 
to reduce their benzos anyway.  So I think pretty much in my practice it had minimal to 
no impact on that cohort of patients
(PRACTICE 1, GP1)
One GP (PRACTICE 2, GP1) noted that with this group there was little willingness or 
motivation to change and the majority of patients in this group would be on a reasonably 
low dose, leading another GP (Practice1, GP1) to conclude that some of the patients are on 
a prescription of benzodiazepine for so long that they are immune to it.  Nonetheless there 
was agreement that it was still important to include this group in the research and that 
the presence of this cohort of patients at the very least served as a reminder to GPs about 
the very real danger of long term prescriptions.  There was also acknowledgement that 
reducing this group’s benzodiazepine use involved tackling long term health beliefs and 
was in itself a much more complex undertaking.
I think the thing about it is, one of the things was, was to try to tackle the belief that 
you know benzos were good for you, and you need to be on them and we were to try 
and get at that health belief, and I think sending a letter out was sort of a shot across 
the bows with that, I mean I think the health beliefs are still very deeply rooted, they 
still believe you know if you’re upset or someone dies you need valium immediately, do 
you know what I mean? It’s like it’s, you can’t just change that, we’ve managed to cut 
down the use, we don’t prescribe new ones, or very rarely, but actually cutting down 
on people who are on chronic scripts, I think we got as far as we can go and we’re not 
going to get any further.
(PRACTICE 2, GP1)
5.6.2 Younger Cohort who are on Methadone Maintenance Programme



























were battling other addictions too apart from benzodiazepines.  This cohort of patients 
was younger, generally on methadone but also facing a range of other addictions.  The 
impact of the introduction of the addiction counsellor to this group was judged to be 
particularly successful with this group.
I think from the point of view of an addiction counsellor, the people that it would have 
particularly helped would have been the methadone, people on cocaine, people eh on 
heroin who didn’t want to go on to methadone but wanted to get off heroin and people 
who had drink problems.  Those would be the big groups I think who actually having 
an addiction counsellor particularly helped.
(PRACTICE2, GP1)
A review of referral forms from mid 2008 to the end of 2010 suggests that of those who 
attended the GP Addiction Project within this time period, a small minority reported 
benzodiazepine as the sole primary drug of choice (n=14). More significant, was the 
reported use of benzodiazepines as an additional drug with a large number of clients 
using benzodiazepines, not as their primary drug of choice (or its use as reason for 
referral), but alongside the problematic use of other drugs for example; alcohol, cocaine, 
methadone etc. Furthermore, for some clients who were referred and attended the 
Addiction Project, benzodiazepines were not part of their drug using behaviour at that 
point in time and other drugs were the primary cause of concern for the client and the GP. 
Given the complexities of addiction and changing patterns of use and drugs of choice for 
an individual, this profile has highlighted the need of the GP Addiction Service to respond 
and engage with all issues of addiction as it presents within the general practitioner setting 
rather than targeting the service specific at benzodiazepine use.
There was overwhelming agreement that the addition of an addiction counsellor to 
the practices involved has been an extremely positive development particularly for the 
methadone using cohort.
It’s come to the point now … within our practice it has enhanced it [the methadone 
programme] so much in terms of patient care, that it would, I would now feel it’s 
almost wrong to have a methadone practice without the option of a readily available 
addiction counsellor with which to refer patients because they’re such a vulnerable 
group and addiction is so intertwined in their lives
(PRACTICE 1, GP1)
In the initial phase of this research project, the perception among the GPs of the numbers 
of long terms users of benzodiazepines was much greater than what was found in reality. 
The fact that benzodiazepine prescribing is not as high as was anticipated has resulted in 
GPs feeling more comfortable about their prescribing rates.  
It certainly got rid of my guilt, because I don’t think we prescribe as much benzos as we 
thought, we had notions there were huge prescriptions coming out and we were totally 
guilty and now we realise no it’s as minimum as we can get it, we’re at a practice level 
we’re as organised as we can and we have to just accept that bit is there and get on 
with it and you feel much cleaner or purer about it.  So it’s been very good from that 
point of view.
(PRACTICE 1, GP1)
One GP noted that the project and the introduction of the counselling service have 
lessened feelings of helplessness in relation to benzodiazepine prescribing. As a result GPs 
are now much more empowered.
It’s just really helpful that there’s just more of a structure and framework and you know, 









































































5.7 Project Integration and Co-ordination 
One of the primary aims of the Project was to pilot the co-location of an addiction 
counselling service within a local GP practice/s. The environment of any GP practice can 
be a highly busy and structured environment in order for needs of all patients to be met. 
The additional delivery of a counselling service, an approach that recognises “talking 
therapy” could be viewed as being in direct contrast to the medical environment wherein it 
is located. One of the counsellors below recalls how her initial reaction to the initiative was 
one which queried her role in a medical setting. 
I actually wondered where my role was as such you know because, the GPs on their 
own seem to do such a good job but obviously there was a place for the talk therapy as 
well.  
(Addiction Counsellor 2)
The GPs in the practice had experience of working in a multi-disciplinary team.  One GP 
noted that there is now a psychologist and community mental health nurse attached to the 
practice, which provides a practical alternative to medication for patients suffering anxiety/ 
panic attacks.  Another GP found that having someone in the practice that was providing 
addiction counselling provided invaluable support for GPs. 
I have taken up someone who is already a patient who was buying on the street and 
has a heavy problem and where I would have ran from it because I couldn’t cope with 
it, I agreed to take her on to detox her.  And the reason I couldn’t cope with it was 
because I didn’t feel skilled but I feel if she is in counselling, addiction counselling and 
committing to that I feel well I feel I can deliver my bit and I feel more secure that I’m 
not a lone soldier.
(PRACTICE1, GP1)
The experience of the nature and extent of integration of the service within the GP practice 
was reported as very positive and complementary to each other’s services. The first 
counsellor felt that it was a good idea for the counselling service to be based in the health 
centre – he felt that it ‘worked powerfully’ as counsellors were seen as part of the team.  
I would see the health service as being a good area because, like the doctors have, in 
one practice there are five doctors, that could be 2000 people or more, and like there, I 
would personally there should be a counsellor attached to every doctor’s practice.  And 
I felt it worked very powerfully.
(Addiction Counsellor 1)
The other counsellor also felt that this presence of an addiction counselling service within 
a general practitioner practice was a great development, in that individuals can avail of 
many different services at once and that these services can then also refer out to more 
specialist services in the community if needs arise.  
It’s almost like, it is ideal. I mean if I would have had this a few years ago you’d kind of 
say, say, ‘God isn’t this fantastic’ because it’s not every little place that has, you know. 
I’ve worked in other areas and it’s not every area that has an almost one stop shop and 
it’s almost like a little centre and it’s from this centre that a whole lot of other ripples go 
out, you know, and I can see where the different services link in. 
          (Addiction Counsellor 2)
Both counsellors felt it made a big difference being on site in the health centre. One of the 



























the community. This point was also reiterated by the other counsellor as outlined below; 
It is a huge bonus I feel it’s, it really is the way to go for the future that everything is 
situated in one building, these people deserve this and an awful lot more. You know, 
that especially for young mums or people who might only be able to get out once or 
twice a week…To have all the different modalities around, it’s fantastic you know.
       (Addiction Counsellor 2)
Because em you were seen as part of the team, you were seen by the person, by the 
patient themselves, you were seen around the place, I’d walk around a bit so ‘there’s 
[Name] the counsellor’, and you’d get people talking to you in general, outside even, 
and it would take away that myth attached to counselling you know.
        (Addiction Counsellor 1)
Both counsellors felt that they were very much part of a team from the very beginning 
of their role as a counsellor within the GP practice. The only limitation of the service 
which was reported by both counsellors was the physical space in which the counselling 
took place. Due to the original layout of the building and availability of rooms, in some 
instance the counsellor would meet a client within the doctor’s surgery. It was felt that 
the arrangement of the room was not overly favourable to the counselling style. Despite 
the physical limitations both counsellors adjusted rooms to maximise their potential 
(for example by moving chairs around, so that the client would not be in view of the 
examination or doctor’s table).  
It is a doctor’s surgery and as you can see it’s equipped as a surgery you know whereas 
in the normal, in the normal counselling mode I suppose you’d be looking for a more 
conducive atmosphere that mightn’t have the distractions or mightn’t have all the bits 
and pieces that remind them of what it’s like to come into a GP. You know, if you had 
this little space, little room, that would have two easy arm chairs, maybe a little table 
that you could but a box of tissues, a glass of water on, a few books, bits and pieces 
of information, you know, that you’d have your own little bits and pieces to hand that 
would be the ideal.
         (Addiction Counsellor 2)
One of the key aims of the research study was to document the inclusion of an addiction 
counselling service to a busy GP practice. Doctors noted once again at follow-up that there 
was a difference in the various approaches and ways of working for both the counsellor 
and/or the general practitioner. Each profession had their distinct remit but could also be 
easily facilitated and supported by the other. 
The work that addiction counsellors do would be so different to the way we would 
interact, even having done the motivational interviewing, it’s just, we’re good if 
someone comes in, and we can make a plan with them to cut down benzos and talk 
with them about what we’re going to do but looking at their whole life and their 
coping skills, and we don’t have time for that and it’s not really, you know, just having 
someone who’s really trained and really focused on that particular side of it, … makes a 
huge difference to people.  
(PRACTICE 2, GP1)
All doctors interviewed had very positive feedback in terms of how well the counsellors 
adapted to, and fitted into, the environment. Moreover, they felt that the presence of 
having an addiction counsellor on site allowed for the issue of ‘addiction’ to be kept to 
the fore and to acknowledge and recognise how extensive it features locally in the lives of 
people and also how central it is to their everyday practice.   







































































 know, they’ve really fitted in well to the practice so it’s very much part of the practice 
now.  
(PRACTICE 2, GP1)
I think it has been extremely positive for the patients or for the clients that she has 
seen herself, but also I think for us, it’s just, she’s been a great source, it’s just, it’s very 
comforting to note that there’s somebody working on addiction, it’s in our face the 
whole time, and then we also have to keep, keep it because you can move on to other 
things, you can take diabetes or something else, you know your interest can move but 
it has kept us, for me anyway, it’s still at the front of my practices, to be mindful of 
addictions, it’s there the whole time.  I think she’s been fantastic.
(PRACTICE 2, GP3)
One doctor commented how different the practice is now with the existence of the 
addiction counsellor and noted how different it would be if this element of the service was 
ever discontinued. 
I’d miss it horrendously if it disappeared.
(PRACTICE 1, GP1)
Doctors at follow-up were asked if having an addiction counsellor on site has changed the 
way they work. All doctors agreed that it did make a difference with one doctor describing 
its impact as making it ‘more holistic in many ways’ (PRACTICE 2, GP 4) and another noting 
that ‘it has definitely enhanced our treatment of patients with addiction, without a doubt’ 
(PRACTICE 1, GP1). Furthermore, there was an opinion among the doctors that having an 
addiction counsellor on site contributed to the overall understanding of addiction and also 
of the person with the addiction as the following quotes highlights; 
The addiction counsellor will get a fuller picture of what’s going on in a person’s life, 
from a social point of view, family point of view, we’ll know the bare bones but there 
will be meat in the bones that she will know about that we probably wouldn’t always 
get access to …
(PRACTICE 2, GP4)
Doctors were also asked if they felt it was effective and if the project could have been 
doing something differently.  A specific example of where doctors at follow-up noted 
the effectiveness of having a counsellor on site was in terms of the early identification or 
intervention -where problems may be starting to emerge for an individual. This feeling is 
exemplified in the following quote:
I think what I’ve found very helpful having her is that if a methadone client, particularly 
them because you see them so much and they’re so vulnerable anyway, if they go off 
the rails you can get in so fast, so if someone comes in and says I’ve started taking a lot 
of tablets or the urines have gone dirty, and she will facilitate and prioritise them you 
can ‘nip it in the bud’ and that’s worth anything, you know. 
(PRACTICE 1, GP1)
One doctor felt that she was very much empowered as a result of the project than she 
initially anticipated; 
I think it would be fair to say we feel much more empowered as a result, three years 
later we’re much more empowered than we were, now would we anyway, who knows? 





























Overall it was felt that the attributes and traits of the counsellor are well suited to a multi-
disciplinary team in that they are often in a position to give a different view of a situation.
But the counsellor does give you a different view on a person, […] now if you’re seeing 
someone weekly or fortnightly for methadone, as you say, you befriend them no matter 
who they are, if you see someone that often you end up friends, which isn’t always a 
good therapeutic relationship and you forget that they can be highly manipulative, do 
you know what I mean? And it takes someone else to assess that from the outside to 
say that, forgotten that almost because you’re seeing them so often.  
(PRACTICE 1, GP1)
5.8 Issues and Challenges 
One of the main perceived issues at the beginning was the difference in ways of working 
and approaches to work. Counselling was perceived to be the “talking therapy” whereby 
the client dictated the pace. This contrasted to the limited time available in the general 
practice to explore more deep-rooted issues with clients. At follow-up, doctors recalled 
once again how there was different ways of working at the beginning as the following 
quote highlights; 
That clash of cultures of the leaving the appointments open and there’s an 
appointment free, get them in, do you know what I mean?  There was a bit of a clash 
of cultures between general practice and counselling and also there was eh a sort of, 
slower uptake because it has to filter through the practice and the population, that this 
is available. 
(PRACTICE 2, GP1)
As noted above one doctor observed the slow initial pace of the project. However, the 
importance of the lead in time in a practice in order to let the new initiative settle in and 
become part of the practice was also conveyed. Another doctor reported how it has been 
a “learning process” for all concerned. It was also noted how, with time, a difference in the 
thinking behind the way counselling worked and the impact that even one consultation 
may have on an individual was evident. 
… so it was a slow, so there is a slow initial phase, until it gets going, I think, as 
you said, that would have to be recognised, accepting that people come for one 
consultation, that’s all they’re able for but that’s actually helpful, just even to have that 
one consultation, you don’t have to go through the twelve consultations and tick a 
box at the end for that to be a useful intervention, seeing someone once can give us 
more insight can give the person some new tips that they can use the next time they 
destabilise, so there was a whole lot of learning that went on to get to where we are 
now which is a very positive stage.  
(PRACTICE 2, GP1)
A key issue highlighted by the GPs was the problem of attendance. Doctors recalled the 
frustration in the initial stages of the project commencement, “when the counsellor had 
four or five appointments and not one would show” (PRACTICE1, GP1). One GP stressed 
that ‘the challenge is for everybody to make sure that the person attends the appointment’ 
(PRACTICE2, GP1). It was noted though that this challenge wasn’t unique to the Project but 
was also similar to other initiatives around psychological interventions (e.g. psychologist, 
community mental health nurse). 
I suppose one of the things is that happens here is that people cope with chaos very 
well and when they don’t cope and they want, they ask for help and will go and talk to 
someone but quite often by the time they’ve done one or two sessions they’ve started 







































































started the chaos in the first place.  
(PRACTICE 2, GP1)
Interestingly one GP felt strongly that improvements in how and when GPs introduced the 
counsellor to patients had made an impact on attendance. 
…people didn’t turn up, now they’re turning up because they’re being better chosen, so 
if they’re being better chosen by us we must have changed our choosing criteria, we’ve 
changed it in order that they will turn up, so we have to have changed the way we 
refer, it’s not just that she is an excellent counsellor.
(PRACTICE 2, GP3)
 
GPs described the current situation as now very different. This increase in attendance was 
largely attributed to the pro-active nature of the current and previous counsellor. In the 
case of the current counsellor, it was noted that her reminder phone call, in addition to 
her non-threatening manner and overall satisfaction among clients helped ensure fewer 
missed appointments. 
She would be doing things like making a phone call on a certain day, I had one patient 
who was particularly vulnerable, so she rang him on a Saturday morning, because we 
were just a bit concerned about him, so she rang as a bit of support, stuff that we don’t 
really do, ringing up somebody, […] that was the priority for her, just to check in with 
that person on a Saturday and get them through the weekend, so you know having 
that sort of support makes a huge difference
(PRACTICE 2, GP1) 
At follow-up, doctors also reported that when the funding for the counsellor position was 
made available, they really were not aware of the various elements of the role, what they 
required, how it would unfold and how would the various disciplines work together within 
the same environment. 
  
... and we had no idea what the person was going to do, we were trying to describe it 
without knowing, whereas the second time we knew what we wanted, so it’s been a 
learning curve for everybody.
(PRACTICE 1, GP1)
Similar to the feedback from the counsellors, doctors acknowledged the physical resources 
and use of scarce space as an issue. The following is an example of a quote which 
highlights this challenge; 
I feel a little bit sorry for her because every time she comes to our practice she’s in a 




Doctors also noted through the interview process on the second occasion that there was 
an emerging keenness from addiction counsellors to work in the general practice and 
to work together in relation to addiction use as it occurs rather than merely within the 
confines of an addiction centre. 
Rather than working out of addiction centre, which many of them had, they preferred 




























5.9 Main Points from In-depth Interviews and Focus Groups with GPs and 
Counsellors
• Two cohorts of benzodiazepine users were identified – an older group who had  
 been using benzos for a significant number of years and a younger cohort who  
 were also on methadone maintenance treatment.  
• GPs felt that the intervention of a letter made little or no difference to the older  
 cohort whereas it was reported to have greater impact on patients who were also  
 experiencing other addictions.
• Counsellors recognised that benzodiazepine addiction is a particularly difficult  
 addiction to deal with. Both described it as a slow process and noted that very  
 often it was the last addiction that patients themselves tried to tackle.
• Both counsellors and GPs noted the effectiveness of the referral system.  The  
 majority of referrals were from GPs, however other agencies in the area did make  
 referrals to the service or provided onward referral options for the client. The   
 importance of linking in with other services was acknowledged and emphasised.
• Despite an initial slow uptake very high attendance rates at the service were   
 observed. A system of encouraging attendance had been adopted by both the  
 counsellors and the practices themselves in terms of issuing reminders to clients.
• The experience of the nature and extent of integration of the service within the 
 practices was reported as very positive and complimentary to each other’s   
 services. There was recognition of the different work practices between GPs and  
 counselling. However, all GPs reported the positive impact the presence of a  
 counsellor on site had; on both them as professionals and on the clients. The only  
 limitation of the service which was reported by counsellors was the physical space  
 in which the counselling took place.
• GPs recognised the importance of training in different approaches as a means  
 of dealing with current benzodiazepine use. In particular, their use of motivational  
 interviewing was an effective strategy for use in primary care. They highlighted  
 their interest in obtaining further training and in particular highlighted the   
 importance of refresher training every few years.
• GPs reported the difficulties of dealing with patients’ expectations in relation to  
 benzodiazepines and in particular the challenges they face when dealing the   
 historical legacy and culture of benzodiazepine use. There was overwhelming  
 agreement by both counsellors and GPs that benzodiazepine use and its reduction 
 is a complex area.
• While GPs were positive about a counselling addiction service, a key concern was  
 the need for any model of counselling to be extremely flexible in order to facilitate  
 clients’ circumstances and needs.
• There was also recognition of the importance of developing a range of strategies  
 that can be employed as alternatives to prescribing benzodiazepines or which  








































































Conclusions and Recommendations 
6.1  An addiction counselling service is an effective strategy to complement existing 
general practitioner practices. 
The evidence from the research conducted found that the integration of an addiction 
counsellor into a GP practice, although not without its challenges, was deemed to be a 
hugely positive development by both GPs and the addiction counsellor, both in terms of 
the service they provided and the support both groups were able to offer to each other. 
The presence of an addiction counsellor provided a holistic and multi-disciplinary view 
of addiction rather than a substance specific approach. The potential value of this service 
being available in a GP setting, particularly to patients also on methadone, is apparent in 
the study. It is clear that the benefits of having an addiction counsellor on site should be 
considered. 
6.2 The delivery of counselling service reported in this research could serve as a model for 
future pilot projects. 
Specific elements of the service including training on motivational interviewing, flexibility, 
system of referral and interventions/strategies to improve attendance (reminder phone 
calls, personal contact) could serve as a model for future developmental projects. However, 
it may be that what works in one geographical context, for many reasons, may not work 
in another. Cultural variations must be taken into consideration and time spent with 
practitioners who have worked in the area, learned or discovered successful strategies 
of information dissemination with patients/clients, for example, will offer benefits to any 
future project.
6.3 The intervention of a letter is an effective intervention in reducing benzodiazepine use
The project endorsed previous research which showed that the writing of a letter from 
a GP to a long term user of benzodiazepines is a cost effective and useful intervention. 
In particular, the results highlight that for those presenting with other addictions as well 
as benzodiazepines (in particular methadone) it can be a simple and effective strategy. 
However, it is recommended in going forward that the dissemination of letters could be 
reviewed to be provided through the GP/receptionist (at the time of contact) rather than 
via postal methods.
6.4 Including a Client Perspective
A limitation of this report is that due to ethical concerns and resources, the client 
perspective on the initiative of having an addiction counsellor on site in a primary care 
setting, was not explored.  Bearing in mind that benzodiazepine addiction is often a 
hidden addiction, future research should take into account the client perspective.  
6.5 Future Work
This project evolved from one that primarily envisaged meeting the needs of clients with a 
benzodiazepine addiction to one that now also has the ability to address other addiction 
issues that may present within a general practitioner setting. The Ballymun Local Drugs 
Task Force will continue to monitor the project and its capacity to respond to clients 
presenting to GPs with addiction problems.
As can be seen from this report, the project provided a tangible way of developing and 
fostering links in the community and promoted a multidisciplinary approach to the issue 



























influence the work of the Primary Health Care Team and the overall primary health care 








































































Ballymun Primary Care Team (2006), Strategy and Progress Report 2002-2007. Ballymun 
Primary Care Team: Dublin. 
Ballymun Youth Action Project (2004) Benzodiazepines-whose little helper? The role of 
Benzodiazepines in the development of substance misuse problems in Ballymun Dublin: 
National Advisory Committee on Drugs.  
Bloor, M., Frankland, J., Thomas, M. and Robson K. (2001) Focus Groups in Social Research.  
Sage Publication
Bryman (2006) ‘Integrating quantitative and qualitative research: how is it done?” 
Qualitative Research 6 (1) p97-113
Clare, A. (1991). The Benzodiazepine Controversy: A Psychiatrist’s reaction. In Gabe, J. (Ed.) 
Understanding Tranquilliser use. The Role of the Social Sciences.   Tavistock/Routledge: 
London. 
Cormack, M., Sweeney, K., Hughes-Jones, H. and Foot, G. (1994) ‘Evaluation of an easy, 
cost-effective strategy for cutting benzodiazepine use in general practice’, British Journal of 
General Practice, 44, 5-8
Delphine Bellerose, Suzi Lyons, Anne Marie Carew, Simone Walsh, Jean Long (2010) 
Problem benzodiazapine use in Ireland: treatment (2003 to 2008) and deaths (1998 to 
2007). Health Research Board: Dublin
Department of Health and Children (2001) Primary Care: A New Direction, Quality and 
Fairness- A Health System for You. Stationary Office: Dublin.
Department of Health and Children (2002) Report of the Benzodiazepine Committee. 
Stationary Office: Dublin.
Department of Sports, Tourism and Recreation (2001) National Drug Strategy 2001-2008: 
Building on Experience. Stationary Office: Dublin. 
Denscombe, M. (2003) The Good Research Guide (2nd Edition) Open University Press
Gorgels, W., Oude Voshaar, R., Mol, A. van de Lisdonk, E., van Balkom, A. van den Hoogen, 
H., Mulder, J., Breteler, H.M., Zitman, G. ‘Discontinuation of long-term benzodiazepine use 
by sending a letter to users in family practice: a prospective controlled intervention study’, 
Drug and Alcohol Dependence 2005; 78, 49-56
Greene, J.C., Caracelli, V.J. and Graham, W.F. (1989) ‘Toward a conceptual Framework for 
Mixed-method Evaluation Designs’, Educational Evaluation and Policy Analysis 11(3): 255-
74
Health Research Board (2010) Drugnet Ireland. Issue 36: Winter 2010. 
HSE Social Inclusion Unit (2010) The introduction of the Opioid Treatment Protocol. Health 
Services Executive: Dublin. 



























2006/2007: Bulletin 2. NACD: Dublin. 
O’Mahony Carey, S (2008) A Guide to Substance Misuse for Medical Professionals HSE 
South. 
Quigley, P. (2001). Public Health Dimensions of Benzodiazepine Regulation. Critical Public 
Health, Vol. 11 (4).
Williams, D. Teljeur, C. Bennett, K. Kelly, A. (2003) Influence of material deprivation 
on prescribing patterns within a deprived population. European Journal of Clinical 
Pharmacology. 59: 559-563.
Zandstra, S.M., Furer, J.W., Van de Lisdonk, E.H., Van’t Hof, M.,Bor, J.H.J., Van Weel,C. & 
Zitman, F.G. (2002) Different study criteria affect the prevalence of benzodiazepine use. 








































































Obtaining GPs’ views on benzodiazepine use in general practice in Ballymun
 ▪ In your experience is prescribing benzodiazepines problematic  
 Probe: why? Can you give examples? Is this just particular to this area? 
 ▪ Can you describe your experience of benzodiazepine use in this community? 
 Probe for examples 
 ▪ What monitoring procedure is in place for benzodiazepine use? 
 Probe: procedures, difficulties if any? 
 ▪ What are your criteria for prescribing benzodiazepines? 
 Probe: does everyone operate the same criteria?  How does it work? 
 ▪ Can you outline any circumstances were benzodiazepines would not be prescribed  
 even at the patient’s request? 
 ▪ Have you explored any alternatives to benzodiazepine use?   
 Probe: Do you have any experience of alternatives? What sort of alternatives have  
 you used?  Do they work/not work? 
 ▪ What are your expectations of having an addiction counsellor on site? 






























Letter sent to Group 1
Dear
I am writing to you because I note from our records that you have been taking ...… for 
some time now.  Recently, family doctors have become concerned about this kind of 
medication when it is taken over long periods.  Our concern is that the body can get 
used to these tablets so that they no longer work properly.  If you stop taking the tablets 
suddenly, there may be unpleasant withdrawal effects that you will experience.  Research 
work done in this field shows that repeated use of the tablets over a long time is no 
longer recommended.  More importantly, these tablets may actually cause anxiety and 
sleeplessness and they can be addictive.
I am writing to ask you to consider cutting down on your dose of these tablets and 
perhaps stopping them at some time in the future. The best way to do this is to take the 
tablets only when you feel you need to.  Try to take them only when you know that you 
have to do something that might be difficult for you.  In this way you might be able to 
make a prescription last longer.
Once you have begun to cut down, you might be able to think about stopping them 
altogether.  It would be best to cut down very gradually and then you will be less likely to 
have withdrawal symptoms.
If you would like to talk to me personally about this, I would be delighted to see you in the 
surgery whenever it is convenient for you to attend.
Yours sincerely










































































Letter sent to Group 2 and Group 3
Dear
I am writing to you because I note from our records that you have been taking …… for 
some time now.  Recently, family doctors have become concerned about this kind of 
medication when it is taken over long periods.  Our concern is that the body can get 
used to these tablets so that they no longer work properly.  If you stop taking the tablets 
suddenly, there may be unpleasant withdrawal effects that you will experience.  Research 
work done in this field shows that repeated use of the tablets over a long time is no 
longer recommended.  More importantly, these tablets may actually cause anxiety and 
sleeplessness and they can be addictive.
I am writing to ask you to consider cutting down on your dose of these tablets and 
perhaps stopping them at some time in the future. The best way to do this is to take the 
tablets only when you feel you need to.  Try to take them only when you know that you 
have to do something that might be difficult for you.  In this way you might be able to 
make a prescription last longer.
Once you have begun to cut down, you might be able to think about stopping them 
altogether.  It would be best to cut down very gradually and then you will be less likely to 
have withdrawal symptoms.  
Recently the services of a counsellor, trained in helping people reduce    use, 
have become available to us and we would like to offer this service to you.  If you would 
like to make an appointment with the counsellor please ring the following number 
  .  In order to find out how effective this service is, later on, a researcher may 
contact people who took up this offer of counselling support. This would be to find out 
what they thought of it.  
The number again to make an appointment to see the counsellor is   .  If you 
would like to discuss these matters personally I would be delighted to see you in the 
surgery whenever it is convenient for you to attend.  
Yours sincerely





























Interview Schedule : Obtaining Addiction Counsellors views on benzodiazepine 
use
Can you tell me about your experience of working as an addiction counsellor in Ballymun? 
How have you found working here?  Is it different from other areas you’ve worked in?
Probe: When did you start working in Ballymun?  How many days are you here? Where 
are you based in the health centre? How many patients would you generally see during a 
week? What would a typical working day be like for you?
What type of client is referred to you?
Can you describe the referral process a client goes through to make contact with you?
Probe: Can a client contact you directly?  What is the protocol for missed appointments?  
How effective is the referral process – what works well, what doesn’t?
What, in general, has been your experience of clients seeking advice on benzodiazepine 
use?
Probe: in your view is benzodiazepine use a major problem?  What are the concerns clients 
express about its use?  Do you have concerns about benzodiazepine use in Ballymun?  
Would any client have mentioned the letter they may have received as part of this study?
To what extent does the counselling covered relate to general drug addiction issues apart 
from just benzo use?
Do you think a counselling service should be on site or in the community?  Why?
How effective do you think a counselling service is in dealing with benzodiazepine 
addiction?
Do you think the gender of the counsellor makes a difference to how effective the service 
is?
Probe: Are there other factors that impact on the effectiveness of the service?
What changes would you make to the counselling service currently on offer to patients?








































































Interview Schedule with GPs
How do you feel the introduction of an addiction counsellor to the practices has worked?
 Probe: Is it very different to how you imagined it to be? How does the    
 integration work?  How do you refer clients?  What in general is the    
 reaction of clients to a referral?  What are the criteria for referring clients?
What difference has it made to your work, if any?
Are there any challenges involved?  
 Probe:  Are there any difficulties with having an addiction counsellor on site? Can  
 you give any examples?  In what way could things be improved?  
How have people found the physical sharing of space?
 Probe: Does this impact on integration?  What has it involved?
One part of the project was the sending of a letter to long-term users of benzodiazepines, 
what impact do you think those letter had?
 Probe: Why do you think it had that impact or lack of impact? Can you give   
 examples?  Why do you think it had that effect?
What impact, if any, has training had in motivational interviewing?
 Probe: Is it effective?  What use has training been?  What do you think about   
 further training?
Was the project worthwhile doing?
 Probe: What were the strengths and weaknesses? Why do you think that – can you  




























Calculating Prescribed Benzodiazepine Use
Both Gorgels et al (2005) and Cormack et al (1994) convert prescribed benzodiazepines 
into diazepam equivalents with Cormack et al. treating 5mg Diazepam as one tablet.
 
The following conversions in this study were used:
Diazepam (Anxicalm, Valium) 5mg 1
Alprazolam (Xanax)  .25mg 1
Bromazepam (Lexotan) 3mg 1
Chlordiazepoxide (Librium) 12.5mg 1
Flurazepam (Dalmane) 7.5mg 1
Flunitrazepam (Rohypnol) .5mg 1
Lormetazepam (Noctamid) 1mg 1
Triazolam (Halcion) .25mg 1
Temazepam (Nortem, Tenox) 10mg 1
Zaleplon (Sonata) 10mg 1
Zolpidem (Stilnoct) 10mg 1
Zopiclone (Zimovane, Zopitan, Zileze) 7.5mg 1



